Case Study: Fast-Tracking Enrollment for a Global Phase 3 Norovirus Vaccine Trial

Case Study High Speed Enrollment for Global Phase 3 Vaccine Clinical Trial

Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The study required a population of generally healthy adults and demanded rapid site activation and participant enrollment to meet aggressive study timelines. Challenge Norovirus, a highly contagious virus causing gastrointestinal illness, presents significant global public health challenges. … Read more

Case Study: Achieving 172% of Enrollment Targets for a Global Phase 3 Trial

Case Study Exceeding Enrollment Targets Global Phase 3 Clinical Trial

Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The trial required a patient population of generally healthy adults aged ≥50, stratified into three age groups. Challenge Vaccine season brings a surge of clinical research activity—especially for flu-related studies. At the time of this trial, several … Read more